GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OliX Pharmaceuticals Inc (XKRX:226950) » Definitions » Long-Term Debt

OliX Pharmaceuticals (XKRX:226950) Long-Term Debt : ₩21,428 Mil (As of Dec. 2024)


View and export this data going back to 2018. Start your Free Trial

What is OliX Pharmaceuticals Long-Term Debt?

OliX Pharmaceuticals's Long-Term Debt for the quarter that ended in Dec. 2024 was ₩21,428 Mil.

OliX Pharmaceuticals's quarterly Long-Term Debt increased from Jun. 2024 (₩25,750 Mil) to Sep. 2024 (₩26,188 Mil) but then declined from Sep. 2024 (₩26,188 Mil) to Dec. 2024 (₩21,428 Mil).

OliX Pharmaceuticals's annual Long-Term Debt increased from Dec. 2022 (₩20,000 Mil) to Dec. 2023 (₩35,362 Mil) but then declined from Dec. 2023 (₩35,362 Mil) to Dec. 2024 (₩21,428 Mil).


OliX Pharmaceuticals Long-Term Debt Historical Data

The historical data trend for OliX Pharmaceuticals's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OliX Pharmaceuticals Long-Term Debt Chart

OliX Pharmaceuticals Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14,011.04 20,000.00 20,000.00 35,361.64 21,428.40

OliX Pharmaceuticals Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 35,361.64 42,221.17 25,750.04 26,188.45 21,428.40

OliX Pharmaceuticals  (XKRX:226950) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.


OliX Pharmaceuticals Long-Term Debt Related Terms

Thank you for viewing the detailed overview of OliX Pharmaceuticals's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


OliX Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
No. 1014 Gwanggyo Ace Tower 1, Daehak 4-ro, Yeongtong-gu, Gyeonggi, Suwon, KOR, 16226
OliX Pharmaceuticals Inc is a clinical stage biotechnology company. It is engaged in developing RNA interference (RNAi) technology therapeutics for dermal, ophthalmic and pulmonary diseases. The company's pipeline products include OLX101, OLX201, OLX301, OLX102, and others.

OliX Pharmaceuticals Headlines

No Headlines